NIH-funded study examines mono, chronic fatigue syndrome in college students

Many college students fully recover from infectious mononucleosis (which is almost always caused by Epstein-Barr virus) within 1-6 weeks, but some go on to develop chronic fatigue syndrome, also called myalgic encephalomyelitis (ME/CFS). A longitudinal study from DePaul University and Northwestern University followed 4,501 college students to examine risk factors that may trigger longer illness.…

Corning Life Sciences to share suite of 3D cell culture technologies at SLAS2021

CORNING, N.Y. — Corning Incorporated (NYSE: GLW) will highlight its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery at this year’s virtual Society for Laboratory Automation and Screening (SLAS) conference on Jan. 25 through 27. Now more than ever, tools used to facilitate scale-up, reproducibility, and consistency of 3D…

NSAIDs might exacerbate or suppress COVID-19 depending on timing, mouse study suggests

Washington, DC – January 22, 2021 – New research shows that non-steroidal anti-inflammatory drugs (NSAIDs) reduced both antibody and inflammatory responses to SARS-CoV-2 infection in mice. The study appears this week in the Journal of Virology, a publication of the American Society for Microbiology. The research is important because “NSAIDs are arguably the most commonly…

Join best-selling author James Nestor on ‘breath’ and sinus health

WHAT: Chronic sinusitis is a major health problem, impacting 30 million Americans. For more than 65 years, the American Rhinologic Society (ARS) has promoted excellence in the care of patients with nose, sinus, and skullbase disorders through research, education, and advocacy. Dedicated to fostering rhinologic research and breakthrough science that advances patient care and improves…

U.S. Vaccine Supply: What to Know

Demand for vaccines is skyrocketing as the United States grapples with a record death toll from Covid-19 and the threat of new, more contagious variants. After a slow start in December, many states and cities have quickly ramped up vaccine delivery, widening access to larger groups of people and setting up mass testing sites. But…